Over the last 6 months PAA had both Michael & John in CEO and COO positions to deliver the activity set. Nothing has changed as far as deliverables go, in fact I expect the workload will only increase over the next 6 - 12 months.
So PharmAust will be needing to recruit.
But given the ASX release clearly has John as interim CEO, is the intention to hire a new CEO, with John in a caretaker role , returning to COO once the hire is complete.
If that is the case, PharmAust may well attract a high profile & high performing biotechnology CEO. The results to date, ODD designation … and the chance to lead commercialising a drug with a mechanism of action that may revolutionise care across neurodegenerative disease. Could be very tempting for the right high flyer.
Every problem creates an opportunity…
Let’s see how this pans out.
Over the last 6 months PAA had both Michael & John in CEO and...
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
17.8¢ |
Change
-0.008(4.05%) |
Mkt cap ! $71.26M | |||
| Open | High | Low | Value | Volume |
| 18.5¢ | 18.5¢ | 17.5¢ | $35.39K | 196.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 220872 | 17.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 18.0¢ | 115000 | 5 |
View Market Depth
| Last trade - 11.36am 28/05/2024 (20 minute delay) ? |
|
|||||
|
Last
17.8¢ |
Change
-0.008 ( 1.39 %) |
||||
| Open | High | Low | Volume | ||
| 18.0¢ | 18.0¢ | 17.5¢ | 567991 | ||
| Last updated 11.21am 28/05/2024 ? | |||||
| PAA (ASX) Chart |